company background image
MD logo

Pediatrix Medical Group NYSE:MD Rapporto sulle azioni

Ultimo prezzo

US$14.61

Cap. di mercato

US$1.2b

7D

-5.7%

1Y

67.5%

Aggiornato

19 Nov, 2024

Dati

Dati finanziari dell'azienda +

Pediatrix Medical Group, Inc.

NYSE:MD Rapporto sulle azioni

Cap. di mercato: US$1.2b

MD Panoramica delle azioni

Pediatrix Medical Group, Inc. insieme alle sue consociate, fornisce servizi di assistenza neonatale, materno-fetale, cardiologica pediatrica e altre sottospecialità pediatriche negli Stati Uniti. Maggiori dettagli

MD analisi fondamentale
Punteggio fiocco di neve
Valutazione4/6
Crescita futura3/6
Prestazioni passate0/6
Salute finanziaria4/6
Dividendi0/6

Pediatrix Medical Group, Inc. Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Pediatrix Medical Group
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$14.61
Massimo di 52 settimaneUS$16.41
Minimo di 52 settimaneUS$6.62
Beta1.56
1Variazione di 1 mese14.50%
Variazione a 3 mesi34.41%
Variazione di 1 anno67.55%
3Variazione a 3 anni-44.64%
Variazione a 5 anni-45.53%
Variazione dall'IPO173.40%

Notizie e aggiornamenti recenti

Pediatrix Medical Group: The Business Is Turning

Nov 18

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Nov 06
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Recent updates

Pediatrix Medical Group: The Business Is Turning

Nov 18

Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Nov 06
Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth

Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden

Oct 19
Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden

We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)

Sep 28
We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)

Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified

Aug 07
Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Jun 19
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

May 10
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 10
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Dec 25
Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Nov 14
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Oct 13
Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Aug 09
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold

Aug 08

At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

Jul 03
At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Jun 08
The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Apr 26
Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Feb 20
Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Pediatrix Medical Group Q4 2022 Earnings Preview

Feb 16

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Jan 12
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold

Dec 22

Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Dec 20
Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Pediatrix appoints James Swift as chief executive officer

Dec 15

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Nov 05
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M

Nov 03

Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29

Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Sep 13
Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Aug 29
Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Jul 27
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14

MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jun 24
MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

May 25
MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

Apr 20
Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 08
MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Feb 15
MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Rendimenti per gli azionisti

MDUS HealthcareUS Mercato
7D-5.7%-5.1%-2.1%
1Y67.5%3.0%29.7%

Ritorno vs Industria: MD ha superato il US Healthcare che ha restituito 3 % nell'ultimo anno.

Rendimento vs Mercato: MD ha superato il mercato US che ha restituito 29.7 % nell'ultimo anno.

Volatilità dei prezzi

Is MD's price volatile compared to industry and market?
MD volatility
MD Average Weekly Movement8.0%
Healthcare Industry Average Movement6.9%
Market Average Movement6.2%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.1%

Prezzo delle azioni stabile: MD non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 8% ) di MD è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19795,450Jim Swiftwww.pediatrix.com

Pediatrix Medical Group, Inc. insieme alle sue consociate, fornisce servizi di assistenza neonatale, materno-fetale, cardiologica pediatrica e altre sottospecialità pediatriche negli Stati Uniti. Offre servizi di assistenza neonatale, come l'assistenza clinica ai bambini nati prematuri o con complicazioni all'interno di specifiche unità ospedaliere attraverso medici neonatologi, infermieri neonatali e altri medici pediatrici. L'azienda fornisce anche servizi di assistenza materno-fetale, compresa l'assistenza clinica in regime di ricovero e in ufficio alle future mamme e ai nascituri attraverso medici specialisti in medicina materno-fetale affiliati, ostetrici e altri medici, tra cui infermieri materno-fetali, ostetriche diplomate, ecografisti e consulenti genetici.

Pediatrix Medical Group, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Pediatrix Medical Group con la sua capitalizzazione di mercato?
MD statistiche fondamentali
Capitalizzazione di mercatoUS$1.22b
Guadagni(TTM)-US$253.84m
Ricavi(TTM)US$2.01b

0.6x

Rapporto P/S

-4.9x

Rapporto P/E

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
MD Conto economico (TTM)
RicaviUS$2.01b
Costo del fatturatoUS$1.58b
Profitto lordoUS$426.99m
Altre speseUS$680.82m
Guadagni-US$253.84m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)-3.00
Margine lordo21.27%
Margine di profitto netto-12.65%
Rapporto debito/patrimonio netto85.6%

Come si è comportato MD nel lungo periodo?

Vedi performance storica e confronto